• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JTS2400107 注射用培重组人凝血因子VIII Lyophilized Biological Products Disposable Import Drug Application 2024-09-25 Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd view
JTS2400109 注射用培重组人凝血因子VIII Lyophilized Biological Products Disposable Import Drug Application 2024-09-25 Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd view
JTS2400106 注射用培重组人凝血因子VIII Lyophilized Biological Products Disposable Import Drug Application 2024-09-25 Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd view
JTS2400110 注射用培重组人凝血因子VIII Lyophilized Biological Products Disposable Import Drug Application 2024-09-25 Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd view
JTS2400104 注射用培重组人凝血因子VIII Lyophilized Biological Products Disposable Import Drug Application 2024-09-25 Baxalta Us Inc;Takeda Canada Inc;Takeda (China) International Trading Co Ltd view
JTS2400105 注射用培重组人凝血因子VIII Lyophilized Biological Products Disposable Import Drug Application 2024-09-25 Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd view
JTS2400108 注射用培重组人凝血因子VIII Lyophilized Biological Products Disposable Import Drug Application 2024-09-25 Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd view
CXSB2300105 注射用培重组人凝血因子VIII-Fc融合蛋白 Lyophilized Biological Products(1) Supplementary Application 2023-10-11 Jiangsu Shengsi Biopharmaceutical Co Ltd view
CXSL2000373 注射用培重组人凝血因子VIII-Fc融合蛋白 Lyophilized Biological Products(1) New Drug Application 2020-12-23 海门晟斯生物制药有限公司 Jiangsu Shengsi Biopharmaceutical Co Ltd In Review 2020-12-22 view
CXSB2300106 注射用培重组人凝血因子VIII-Fc融合蛋白 Lyophilized Biological Products(1) Supplementary Application 2023-10-11 Jiangsu Shengsi Biopharmaceutical Co Ltd view
CXSL2000372 注射用培重组人凝血因子VIII-Fc融合蛋白 Lyophilized Biological Products(1) New Drug Application 2020-12-23 海门晟斯生物制药有限公司 Jiangsu Shengsi Biopharmaceutical Co Ltd In Review 2020-12-22 view
CXSS1900042 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(10) New Drug Application 2019-11-19 神州细胞工程有限公司 SinoCelltech Ltd Certificate Issued 2021-07-28 view
JXSS1000007 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Import Drug Application 2010-09-15 Wyeth Farma SA;Wyeth Pharmaceuticals Inc Certificate Issued 2012-08-28 view
JXSL0800021 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Import Drug Application 2008-08-13 Baxter S.A. Baxter SA Certificate Issued 2010-12-27 view
JYSB2400251 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-12-04 Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG view
JYSB1500127 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2015-05-08 Wyeth Farma SA;Wyeth Pharmaceuticals Inc Certificate Issued 2015-08-12 view
JYSZ1800032 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products License Renew 2018-07-20 Bayer Healthcare LLC Certificate Issued 2019-06-03 view
JYSZ2200030 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products License Renew 2022-06-29 Pfizer Europe Ma Eeig;Wyeth Farma SA;Pfizer Investment Co Ltd view
JYSB1400185 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2014-09-01 拜耳医药保健有限公司 Bayer Healthcare Company Ltd;Bayer Healthcare LLC Certificate Issued 2014-11-25 view
JYSB2100025 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2021-01-22 Pfizer Europe Ma Eeig;Wyeth Farma SA In Review 2021-01-21 view